{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:52:00Z","timestamp":1791219120256,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4632,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ymthe.2003.11.015","type":"journal-article","created":{"date-parts":[[2003,12,19]],"date-time":"2003-12-19T12:14:35Z","timestamp":1071836075000},"page":"231-240","source":"Crossref","is-referenced-by-count":125,"title":["AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of \u03b1-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice"],"prefix":"10.1016","volume":"9","author":[{"given":"Robin J","family":"Ziegler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M","family":"Lonning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Armentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribeth","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M","family":"Barbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrie J","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C","family":"Wadsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2003.11.015_BIB1","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3733","article-title":"\u03b1-Galactosidase A deficiency: fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000247189","article-title":"Fabry's disease: heterozygous form of different expression in two monozygous twin sisters","volume":"187","author":"Marguery","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson\u2013Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of \u03b1-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB8","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.1073\/pnas.93.15.7917","article-title":"Correction in trans for Fabry disease: expression, secretion and uptake of \u03b1-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector","volume":"93","author":"Medin","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1089\/10430349950017671","article-title":"Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer","volume":"10","author":"Ziegler","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1006\/mthe.2002.0605","article-title":"Adenovirus-transduced lung as a portal for delivering \u03b1-galactosidase A into systemic circulation for Fabry disease","volume":"5","author":"Li","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB11","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.222221899","article-title":"Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer","volume":"99","author":"Takahashi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB12","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.0537900100","article-title":"Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer","volume":"100","author":"Park","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/sj.gt.3302092","article-title":"Gene therapy progress and prospects: gene therapy of lysosomal storage disorders","volume":"10","author":"Cheng","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/10430340252939041","article-title":"Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease","volume":"13","author":"Ziegler","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB15","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1073\/pnas.051634498","article-title":"Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice","volume":"98","author":"Jung","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V90.1.43","article-title":"Enzyme therapy in Gaucher disease type I: effect of neutralizing antibodies to acid \u03b2-glucosidase","volume":"90","author":"Ponce","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB18","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB19","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1128\/JVI.72.12.10222-10226.1998","article-title":"Adeno-associated virus as a vector for liver-directed gene therapy","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB20","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1089\/10430349950017455","article-title":"Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors","volume":"10","author":"Pastore","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood.V97.5.1258","article-title":"Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA","volume":"97","author":"Nathwani","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mthe.2000.0031","article-title":"Sustained expression of therapeutic level of Factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver","volume":"1","author":"Wang","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14712598.2.3.325","article-title":"Advances in the management of Anderson\u2013Fabry disease: enzyme replacement therapy","volume":"2","author":"Pastores","year":"2002","journal-title":"Exp. Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/13518","article-title":"Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors","volume":"5","author":"Snyder","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/mgme.2000.2979","article-title":"Enzyme replacement therapy in mucopolysaccharidosis I: altered distribution and targeting of \u03b1-l-iduronidase in immunized rats","volume":"69","author":"Turner","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB27","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood-2002-07-2146","article-title":"Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells","volume":"101","author":"De Geest","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB28","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.72.5.4212-4223.1998","article-title":"Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers","volume":"72","author":"Jooss","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0528.2002.017408.x","article-title":"Local control of the immune response in the liver","volume":"174","author":"Knolle","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB30","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood.V93.6.2081.406k07_2081_2088","article-title":"Immunosurveillance of aglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration","volume":"93","author":"Rosenberg","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB31","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB32","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB33","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0042-6822(89)90531-X","article-title":"Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor","volume":"171","author":"Chejanovsky","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1073\/pnas.94.2.575","article-title":"Characterization of the chicken beta-globin insulator","volume":"94","author":"Chung","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-1119(83)90217-2","article-title":"Cloning of infectious adeno-associated virus genomes in bacterial plasmids","volume":"23","author":"Laughlin","year":"1983","journal-title":"Gene"},{"key":"10.1016\/j.ymthe.2003.11.015_BIB37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/MCB.10.3.991","article-title":"Binding of a liver-specific factor to the human albumin gene promoter and enhancer","volume":"10","author":"Frain","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB38","doi-asserted-by":"crossref","first-page":"18927","DOI":"10.1016\/S0021-9258(18)55152-8","article-title":"Characterization of a novel liver-specific enhancer in the human prothrombin gene","volume":"266","author":"Chow","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB39","first-page":"A208","article-title":"Generation of a mouse model with \u03b1-galactosidase A deficiency","volume":"59","author":"Wang","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2003.11.015_BIB40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/abio.1998.2966","article-title":"Quantitative determination of globotriaosylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit","volume":"267","author":"Zeidner","year":"1999","journal-title":"Anal. Biochem."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001603003678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001603003678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T15:51:52Z","timestamp":1623599512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001603003678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1525001603003678"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2003.11.015","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}